TY - JOUR
T1 - Young people's perspectives on patient-reported outcome measures in inflammatory arthritis
T2 - Results of a multicentre European qualitative study from a EULAR task force
AU - Mosor, Erika
AU - Studenic, Paul
AU - Alunno, Alessia
AU - Padjen, Ivan
AU - Olsder, Wendy
AU - Ramiro, Sofia
AU - Bini, Ilaria
AU - Caeyers, Nele
AU - Gossec, Laure
AU - Kouloumas, Marios
AU - Nikiphorou, Elena
AU - Stones, Simon
AU - Wilhelmer, Tanita Christina
AU - Stamm, Tanja A.
N1 - Funding Information:
Funding This project was funded by the EULAR; grant number CLI100.
Publisher Copyright:
© 2021 BMJ Publishing Group. All rights reserved.
PY - 2021/1/29
Y1 - 2021/1/29
N2 - Introduction Although patient-reported outcome measures (PROMs) are increasingly used in clinical practice and research, it is unclear whether these instruments cover the perspective of young people with inflammatory arthritis (IA). The aims of this study were to explore whether PROMs commonly used in IA adequately cover the perspective of young people from different European countries. Methods A multinational qualitative study was conducted in Austria, Croatia, Italy and the Netherlands. Young people with either rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), Still's disease, psoriatic arthritis (PsA) or spondyloarthritis (SpA), aged 18-35 years, participated in semistructured focus group interviews. Thematic analysis was used and data saturation was defined as no new emergent concepts in at least three subsequent focus groups. Results Fifty-three patients (21 with RA/JIA/Still's, 17 with PsA, 15 with SpA; 72% women) participated in 12 focus groups. Participants expressed a general positive attitude towards PROMs and emphasised their importance in clinical practice. In addition, 48 lower level concepts were extracted and summarised into 6 higher level concepts describing potential issues for improvement. These included: Need for lay-term information regarding the purpose of using PROMs; updates of certain outdated items and using digital technology for data acquisition. Some participants admitted their tendency to rate pain, fatigue or disease activity differently from what they actually felt for various reasons. Conclusions Despite their general positive attitude, young people with IA suggested areas for PROM development to ensure that important concepts are included, making PROMs relevant over the entire course of a chronic disease.
AB - Introduction Although patient-reported outcome measures (PROMs) are increasingly used in clinical practice and research, it is unclear whether these instruments cover the perspective of young people with inflammatory arthritis (IA). The aims of this study were to explore whether PROMs commonly used in IA adequately cover the perspective of young people from different European countries. Methods A multinational qualitative study was conducted in Austria, Croatia, Italy and the Netherlands. Young people with either rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), Still's disease, psoriatic arthritis (PsA) or spondyloarthritis (SpA), aged 18-35 years, participated in semistructured focus group interviews. Thematic analysis was used and data saturation was defined as no new emergent concepts in at least three subsequent focus groups. Results Fifty-three patients (21 with RA/JIA/Still's, 17 with PsA, 15 with SpA; 72% women) participated in 12 focus groups. Participants expressed a general positive attitude towards PROMs and emphasised their importance in clinical practice. In addition, 48 lower level concepts were extracted and summarised into 6 higher level concepts describing potential issues for improvement. These included: Need for lay-term information regarding the purpose of using PROMs; updates of certain outdated items and using digital technology for data acquisition. Some participants admitted their tendency to rate pain, fatigue or disease activity differently from what they actually felt for various reasons. Conclusions Despite their general positive attitude, young people with IA suggested areas for PROM development to ensure that important concepts are included, making PROMs relevant over the entire course of a chronic disease.
UR - http://www.scopus.com/inward/record.url?scp=85100577200&partnerID=8YFLogxK
U2 - 10.1136/rmdopen-2020-001517
DO - 10.1136/rmdopen-2020-001517
M3 - Article
C2 - 33514672
AN - SCOPUS:85100577200
SN - 2056-5933
VL - 7
JO - RMD Open
JF - RMD Open
IS - 1
M1 - 1517
ER -